+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Kadmon Corporation - logo

Kadmon is a fully integrated biopharmaceutical company that focuses on small molecules and biologics to address disease areas of significant unmet medical need. The company is developing product candidates within autoimmune and fibrotic diseases, oncology and genetic diseases. Its lead product candidates is KD025, a rho-associated coiled-coil kinase2 inhibitor, which is in Phase II clinical studies for the treatment of autoimmune, fibrotic, and neurodegenerative diseases. The company is headquartered in New York.

Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018

  • Report
  • 344 Pages
From
Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2019 - Product Thumbnail Image

Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2019

  • Drug Pipelines
  • 370 Pages
From
Global Monoclonal Antibody Partnering Terms and Agreements 2014 to 2019 - Product Thumbnail Image

Global Monoclonal Antibody Partnering Terms and Agreements 2014 to 2019

  • Report
  • 450 Pages
From
Scleroderma Therapeutics Market - Growth, Trends, and Forecast (2020 - 2025) - Product Thumbnail Image

Scleroderma Therapeutics Market - Growth, Trends, and Forecast (2020 - 2025)

  • Report
  • 114 Pages
From
Hepatitis C Treatment - Market Analysis, Trends, and Forecasts - Product Thumbnail Image

Hepatitis C Treatment - Market Analysis, Trends, and Forecasts

  • Report
  • 155 Pages
From
Chronic Kidney Disease Market: Pipeline Review, Developer Landscape and Competitive Insights - Product Thumbnail Image

Chronic Kidney Disease Market: Pipeline Review, Developer Landscape and Competitive Insights

  • Report
  • 164 Pages
From
Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H1 2019 - Product Thumbnail Image

Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H1 2019

  • Drug Pipelines
  • 40 Pages
From
Graft versus Host Disease (GvHD) - Market Insights, Epidemiology and Market Forecast - 2027 - Product Thumbnail Image

Graft versus Host Disease (GvHD) - Market Insights, Epidemiology and Market Forecast - 2027

  • Drug Pipelines
  • 222 Pages
From
Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2019 - Product Thumbnail Image

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2019

  • Drug Pipelines
  • 671 Pages
From
Chronic Plaque Psoriasis - Pipeline Insight, 2019 - Product Thumbnail Image

Chronic Plaque Psoriasis - Pipeline Insight, 2019

  • Drug Pipelines
  • 70 Pages
From
Psoriasis - Pipeline Review, H2 2019 - Product Thumbnail Image

Psoriasis - Pipeline Review, H2 2019

  • Drug Pipelines
  • 803 Pages
From
Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H1 2019 - Product Thumbnail Image

Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H1 2019

  • Drug Pipelines
  • 47 Pages
From
2019 Polycystic Kidney Disease Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 Polycystic Kidney Disease Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • 96 Pages
From
Global Type 2 Diabetes Market 2016-2020 - Product Thumbnail Image

Global Type 2 Diabetes Market 2016-2020

  • Report
  • 122 Pages
From
Immune Checkpoint Inhibitors: Clinical Trial Tracker - Product Thumbnail Image

Immune Checkpoint Inhibitors: Clinical Trial Tracker

  • Clinical Trials
From
Rheumatoid Arthritis - Pipeline Review, H2 2019 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2019

  • Drug Pipelines
  • 1148 Pages
From
NASH Drugs Market, 2015 - 2025 - Product Thumbnail Image

NASH Drugs Market, 2015 - 2025

  • Report
  • 188 Pages
From
Type 2 Diabetes - Pipeline Review, H1 2018 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Review, H1 2018

  • Drug Pipelines
  • 1109 Pages
From
Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2014- 2019 - Product Thumbnail Image

Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2014- 2019

  • Report
  • 1000 Pages
From
Rheumatoid Arthritis - Pipeline Review, H2 2017 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2017

  • Drug Pipelines
  • 1051 Pages
From
Loading Indicator
adroll